Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
<p>Abstract</p> <p>Background</p> <p>Indacaterol is a once-daily long-acting inhaled β<sub>2</sub>-agonist indicated for maintenance treatment of moderate-to-severe chronic obstructive pulmonary disease (COPD). The large inter-patient and inter-study variability in forced expiratory volume in 1 seco...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2011-04-01
|
| Series: | Respiratory Research |
| Acceso en liña: | http://respiratory-research.com/content/12/1/54 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
